Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis

Clinical and Experimental Rheumatology

Volumn 27, Issue 1 SUPPL. 52, 2009, Pages

  Finkielman, Javier D ^a   Merkel, Peter A ^b   Schroeder, Darrell ^a   Hoffman, Gary S ^c   Spiera, Robert ^d   St Clair, E William ^e   Davis Jr , John C ^f   McCune, W Joseph ^g   Lears, Andrea ^h   Ytterberg, Steven R ^a   Hummel, Amber M ^a   Viss, Margaret A ^a   Peikert, Tobias ^a   Stone, John H ^h   Specks, Ulrich ^a  

^a MAYO CLINIC   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d HOSPITAL FOR SPECIAL SURGERY   (United States)

^e DUKE UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

ANCA; Biological markers; Glycosylation; Proteinase 3; Wegener's granulomatosis

Indexed keywords

MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGLYCOSYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GLYCOSYLATION; HUMAN; LONGITUDINAL STUDY; MULTICENTER STUDY; POPULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SERUM; WEGENER GRANULOMATOSIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIGEN-ANTIBODY REACTIONS; CELL LINE, TRANSFORMED; FEMALE; GLYCOSYLATION; HUMANS; MALE; MIDDLE AGED; MYELOBLASTIN; WEGENER GRANULOMATOSIS;

EID: 70450245262     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. CSERNOK E, LUDEMANN J, GROSS WL, BAINTON DF: Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Am J Pathol 1990; 137: 1113-1120
2. JENNE DE, TSCHOPP J, LÜDEMANN J, UTECHT B, GROSS WL: Wegener's autoantigen decoded. Nature 1990; 346: 520.
3. HOFFMAN GS, KERR GS, LEAVITT RY et al.: Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-498
4. REINHOLD-KELLER E, BEUGE N, LATZA U et al.: An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000; 43: 1021-1032
5. JENNE DE, FRÖHLICH L, HUMMEL AM, SPECKS U: Cloning and functional expression of the murine homologue of proteinase 3: implications for the design of murine models of vasculitis. FEBS Lett 1997; 408: 187-90.
6. SPECKS U, FASS DN, FINKIELMAN JD et al.: Functional significance of Asn-linked glycosylation of proteinase 3 for enzymatic activity, processing, targeting, and recognition by anti-neutrophil cytoplasmic antibodies. J Biochem (Tokyo) 2007; 141: 101-112
7. BUZAS EI, GYÖRGY B, PASZTOI M, JELINEK I, FALUS A, GABIUS H: Carbohydrate recognition systems in autoimmunity. Autoimmunity 2006; 39: 691-704.
8. DOYLE HA, MAMULA MJ: Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol 2001; 22: 443-449
9. RUDD PM, ELLIOTT T, CRESSWELL P, WILSON IA, DWEK RA: Glycosylation and the immune system. Science 2001; 291: 2370-2376
10. FILLIT H, SHIBATA S, SASAKI T, SPIERA H, KERR LD, BLAKE M: Autoantibodies to the protein core of vascular basement membrane heparan sulfate proteoglycan in systemic lupus erythematosus. Autoimmunity 1993; 14: 243-249 (Pubitemid 23184824)
11. GAHRING L, CARLSON NG, MEYER EL, ROGERS SW: Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation. J Immunol 2001; 166: 1433-1438
12. CASCIOLA-ROSEN L, ANDRADE F, ULANET D, WONG WB, ROSEN A: Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999; 190: 815-826
13. MCCORMICK TS, ROWLAND EC: Trypanosoma cruzi: recognition of a 43-kDa muscle glycoprotein by autoantibodies present during murine infection. Exp Parasitol 1993; 77: 273-281 (Pubitemid 2007856)
14. SEETHARAMAIAH GS, DALLAS JS, PATIBANDLA SA, THOTAKURA NR, PRABHAKAR BS: Requirement of glycosylation of the human thyrotropin receptor ectodomain for its reactivity with autoantibodies in patients' sera. J Immunol 1997; 158: 2798-2804
15. BLASS S, MEIER C, VOHR HW, SCHWOCHAU M, SPECKER C, BURMESTER GR: The p68 autoantigen characteristic of rheumatoid arthritis is reactive with carbohydrate epitope specific autoantibodies. Ann Rheum Dis 1998; 57: 220-225
16. SUN J, FASS DN, HUDSON JA et al.: Capture-ELIS A based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes. J Immunol Methods 1998; 211: 111-123
17. FUJINAGA M, CHERNAIA MM, HALENBECK R, KOTHS K, JAMES MN: The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies. J Mol Biol 1996; 261: 267-278
18. LEE AS, FINKIELMAN JD, PEIKERT T, HUMMEL AM, VISS MA, SPECKS U: A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases. J Immunol Methods 2005; 307: 62-72.
19. CAPIZZI SA, VISS MA, HUMMEL AM, FASS DN, SPECKS U: Effects of carboxy-terminal modifications of proteinase 3 (PR3) on the recognition by PR3-ANCA. Kidney Int 2003; 63: 756-760
20. SUN J, FASS DN, VISS MA et al.: A proportion of proteinase 3-specific anti-neutrophil cytoplasmic antibodies only react with proteinase 3 after cleavage of its N-terminal activation dipepttde. Clin Exp Immunol 1998; 114: 320-6.
21. THE WGET RESEARCH GROUP: Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005; 352: 351-361
22. THE WGET RESEARCH GROUP: Design of the Wegener's granulomatosis etanercept trial (WGET). Control Clin Trials 2002; 23: 450-68.
23. THE WGET RESEARCH GROUP: Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum 2003; 48: 2299-2309
24. FINKIELMAN JD, LEE AS, HUMMEL AM et al.: ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis. Am J Med 2007; 120: 643 e9-14.
25. WITKO-SARSAT V, HALBWACHS-MECARELLI L, ALMEIDA RP et al.: Characterization of a recombinant proteinase 3, the autoantigen in Wegener's granulomatosis and its reactivity with anti-neutrophil cytoplasmic autoantibodies. FEBS Letters 1996; 382: 130-136
26. HELLMICH B, CSERNOK E, FREDENHAGEN G, GROSS WL: A novel high sensitivity ELISA for the detection of antineutrophil cytoplasmic antibodies against proteinase-3. Clin Exp Rheumatol 2007; 25 (Suppl. 44): Sl-5.
27. ITO-IHARA T, MUSO E, KOBAYASHI S et al.: A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytolasm antibodies available in Japan and Europe. Clin Exp Rheumatol 2008; 26: 1027-1033